← All Sponsors
SPONSOR

CHU de Reims

Total Trials
4
Recruiting
4
Phases
Phase 4

CHU de Reims is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Urinary Retention, Infectious Keratitis, Microbial Keratitis, Corneal Infection.

The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — CHU de Reims

How many clinical trials has CHU de Reims sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by CHU de Reims, of which 4 are actively recruiting participants. These trials cover conditions including Urinary Retention, Infectious Keratitis, Microbial Keratitis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does CHU de Reims research focus on?
CHU de Reims clinical trials span Urinary Retention, Infectious Keratitis, Microbial Keratitis, Corneal Infection, Diabetic Retinopathy, and additional conditions. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a CHU de Reims clinical trial?
To participate in a CHU de Reims trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all CHU de Reims trials with current recruitment status updated daily.

Clinical Trials by CHU de Reims

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology